1. Azuma, J., Sawamura, A., Awata, N., Hasegawa, H., Ogura, K., Harada, H., Ohta, H., Yamauchi, K., Kishimoto, S., Yamagami, T., Ueda, E., and Ishiyama, T., 1983, Double-blind randomized crossover trial of taurine in congestive heart failure, Curr. Therapeut. Res., 34:543–557.
2. Azuma, J. and Schaffer, S.W., 1995, Protective effect of taurine on the failing heart and its possible mechanism of action, in: “The Failing Heart”, Dhalla, N.S., Beamish, R.E., Takeda, N. and Nagano, M., eds., Lippincott-Raven Publishers, Philadelphia, pp. 421–431.
3. Ballard-Croft, C., Mozaffari, M.S., Azuma, J., and Schaffer, S., Interaction between taurine and angiotensin II: Modulation of calcium transport and myocardial contractile function, Amino Acids, in press.
4. Blank, P.S., Silverman, H.S., Chung, O.Y., Hogue, B.A., Stern, M.D., Hansford, R.G., Lakatta, E.G., and Capogrossi, M.C., 1992, Cytosolic pH measurements in single cardiac myocytes using carboxy-seminaphthorhodafluor-1, Am. J. Physiol., 263:H276–H284.
5. DeTata, V., Del Roso, A., Gori, Z., and Bergamini, E., 1990, Effects of the administration of angiotensin II on cardiac glycogen metabolism in the rat, Eur. J. Physiol., 416:673–678.